ArticleCancer communications (London, England)2026
First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression.
Ru Jia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.